International differences in cardiovascular clinical trials

被引：6

作者：

O'Shea, JC ^{[1
]}

Califf, RM ^{[1
]}

机构：

[1] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA

来源：

AMERICAN HEART JOURNAL | 2001年 / 141卷 / 05期

关键词：

D O I：

10.1067/mhj.2001.114982

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：866 / 874

页数：9

共 31 条

[1]

[Anonymous], 1986, Lancet, V2, P57

[2] COMPARATIVE CASE FATALITY ANALYSIS OF THE INTERNATIONAL TISSUE PLASMINOGEN-ACTIVATOR STREPTOKINASE MORTALITY TRIAL - VARIATION BY COUNTRY BEYOND PREDICTIVE PROFILE [J].

BARBASH, GI ;

MODAN, M ;

GOLDBOURT, U ;

WHITE, HD ;

VANDEWERF, F .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 21 (02) :281-286

[3] Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation results from an international trial of 9461 patients [J].

Boersma, E ;

Pieper, KS ;

Steyerberg, EW ;

Wilcox, RG ;

Chang, WC ;

Lee, KL ;

Akkerhuis, KM ;

Harrington, RA ;

Deckers, JW ;

Armstrong, PW ;

Lincoff, AM ;

Califf, RM ;

Topol, EJ ;

Simoons, ML .

CIRCULATION, 2000, 101 (22) :2557-2567

[4] A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST) [J].

Califf, RM ;

Adams, KF ;

McKenna, WJ ;

Gheorghiade, M ;

Uretsky, BF ;

McNulty, SE ;

Darius, H ;

Schulman, K ;

Zannad, F ;

HandbergThurmond, E ;

Harrell, FE ;

Wheeler, W ;

SolerSoler, J ;

Swedberg, K .

AMERICAN HEART JOURNAL, 1997, 134 (01) :44-54

[5] A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease [J].

Cohen, M ;

Demers, C ;

Gurfinkel, EP ;

Turpie, AGG ;

Fromell, GJ ;

Goodman, S ;

Langer, A ;

Califf, RM ;

Fox, KAA ;

Premmereur, J ;

Bigonzi, F .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (07) :447-452

[6] Variation in patient management and outcomes for acute coronary syndromes in Latin America and North America:: Results from the Platelet IIb/IIIa in Unstable Angina:: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial [J].

Cohen, MG ;

Pacchiana, CM ;

Corbalán, R ;

Perez, JEI ;

Ponte, CI ;

Oropeza, ES ;

Diaz, R ;

Paolasso, E ;

Izasa, D ;

Rodas, MA ;

Urrutia, CE ;

Harrington, RA ;

Topol, EJ ;

Califf, RM .

AMERICAN HEART JOURNAL, 2001, 141 (03) :391-401

[7]

DEVITA C, 1994, LANCET, V343, P1115

[8] Use of evidence-based medical therapy in patients undergoing percutaneous coronary revascularization in the United States, Europe, and Canada [J].

Eisenberg, MJ ;

Califf, RM ;

Cohen, EA ;

Adelman, AG ;

Mark, DB ;

Topol, EJ .

AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (07) :867-872

[9] Differences in the treatment of coronary heart disease between countries as revealed in the Scandinavian Simvastatin Survival Study (4S) [J].

Faergeman, O ;

Kjekshus, J ;

Cook, T ;

Pyorala, K ;

Wilhelmsen, L ;

Thorgeirsson, G ;

Pedersen, TR .

EUROPEAN HEART JOURNAL, 1998, 19 (10) :1531-1537

[10] Inter-regional differences and outcome in unstable angina - Analysis of the International ESSENCE trial [J].

Fox, KAA ;

Goodman, S ;

Bigonzi, F ;

Le Louer, V ;

Cohen, M .

EUROPEAN HEART JOURNAL, 2000, 21 (17) :1433-1439

← 1 2 3 4 →